-
1.发明申请GLUCAGON RECEPTOR ANTAGONIST COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE 有权GLUCAGON受体拮抗剂化合物，包含这些化合物的组合物和使用方法公开(公告)号：US20160250184A1
公开(公告)日：2016-09-01
申请号：US15030779
申请日：2014-10-30
Applicant: Songnian LIN , Libo XU , Emma R. PARMEE , Xibin LIAO , MERCK SHARP & DOHME CORP.
Inventor： SONGNIAN LIN , Libo Xu , Emma R. Parmee , Xibin Liao
IPC: A61K31/404 , A61K45/06 , A61K31/397 , C07D209/20
CPC classification number: A61K31/404 , A61K31/397 , A61K31/4035 , A61K45/06 , C07D209/18 , C07D209/20 , A61K2300/00
Abstract: Glucagon receptor antagonist compounds are disclosed which are of long duration of action. The compounds are useful for treating type 2 diabetes and related conditions. Pharmaceutical compositions and methods of treatment are also included.
Abstract translation: 披露了长时间作用的胰高血糖素受体拮抗剂化合物。 该化合物可用于治疗2型糖尿病及相关病症。 还包括药物组合物和治疗方法。
-
2.发明授权公开(公告)号：US09649294B2
公开(公告)日：2017-05-16
申请号：US15030779
申请日：2014-10-30
Applicant: Merck Sharp & Dohme Corp.
Inventor： Songnian Lin , Libo Xu , Emma R. Parmee , Xibin Liao
IPC: A61K31/404 , C07D209/18 , A61K45/06 , A61K31/397 , A61K31/4035 , C07D209/20
CPC classification number: A61K31/404 , A61K31/397 , A61K31/4035 , A61K45/06 , C07D209/18 , C07D209/20 , A61K2300/00
Abstract: Glucagon receptor antagonist compounds are disclosed which are of long duration of action. The compounds are useful for treating type 2 diabetes and related conditions. Pharmaceutical compositions and methods of treatment are also included.
-
Search Results
2
records
(took 0.012 seconds)
